ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135037 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135037; 2) Community: the network communities that were significantly associated with the response to NSC 135037; 3) Molecule: the relationships between components within communities and NSC 135037; 4) MDR: the compounds that were significantly associated with the NSC 135037.

NSC Compound Enrichment Correlation
NSC 728132 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene 0.0352383000003056 0.545609
NSC 743556 Null 0.0352383000003056 0.45242004
NSC 747169 Null 0.0352383000003056 0.74372348
NSC 756833 Null 0.0352383000003056 -0.34378559
NSC 758965 CEPHARANTHINE 0.0352383000003056 0.27670666
NSC 759322 MEVASTATIN 0.0352383000003056 -0.16156867
NSC 99027 Null 0.0352383000003056 0.61423244
NSC 135168 Null 0.0352786308082228 0.22585398
NSC 205795 Benzoic acid, 4-[[(2-thiazolylamino)carbonyl]amino]-, ethyl ester (9CI) 0.0352786308082228 0.076438108
NSC 3080 s-Triazine, 4,6-diamino-1-(m-chlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0352786308082228 0.10925049
Total:92  Current:70    [First] [Prev] [Next] [Last]